Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cardinal Health to buy pharmaceutical distributor Kinray for $1.3 billion
Pharmabiz
Saturday, November 20, 2010 - 12:53pm
tags:
Cardinal Health, Kinray
Clarus Therapeutics Files To Sell Up To $86.3M In Shares In IPO
WSJ
Saturday, November 20, 2010 - 12:47pm
tags:
Clarus Therapeutics, OriTex, testosterone
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Saturday, November 20, 2010 - 12:46pm
tags:
Helix BioPharma, topical interferon Alpha-2b, cervical lesions, cervical cancer
Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial
Yahoo/BusinessWire
Saturday, November 20, 2010 - 12:41pm
tags:
Merck, Fosamax, lawsuits
Why Brazil’s Pharmerging Market Can’t Be Ignored
Seeking Alpha
Saturday, November 20, 2010 - 12:35pm
tags:
Brazil
Scrutiny of Big Pharma set to intensify (In UK)
Financial Times, UK
Saturday, November 20, 2010 - 12:34pm
tags:
Big Pharma
Names You Need To Know: Pradaxa and Xarelto
Forbes
Saturday, November 20, 2010 - 12:24pm
tags:
Boehringer Ingelheim, Bayer, JNJ, Pradaxa, Xarelto, blood thinners
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Saturday, November 20, 2010 - 12:22pm
tags:
Amgen, Prolia, Xgeva, denosumab
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Saturday, November 20, 2010 - 12:20pm
tags:
Merck, CETP inhibitors, Anacetrapib, cholesterol
Anavex Announces Private Placement
BusinessWire
Saturday, November 20, 2010 - 12:17pm
tags:
Anavex, Alzheimer's disease, SIGMACEPTOR, cancer
Exclusive Picks From Street’s Top Biotech Analyst
CNBC
Saturday, November 20, 2010 - 12:15pm
tags:
Human Genome Sciences, Amgen, United Therapeutics
Sanofi Buyout Target Genzyme to Meet U.S. Deadline to Change Manufacturing
Bloomberg
Saturday, November 20, 2010 - 12:14pm
tags:
Sanofi, Genzyme
Molecular Insight Receives Extension of Waiver Agreement With Bond Holders
Yahoo/MarketWire
Saturday, November 20, 2010 - 12:13pm
tags:
Molecular Insight
Regeneron Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration
Yahoo/PR NewsWire
Saturday, November 20, 2010 - 12:12pm
tags:
Regeneron, VEGF Trap-Eye, macular degeneration, age-related macular degeneration
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer Patients
Bloomberg
Saturday, November 20, 2010 - 12:10pm
tags:
Amgen, denosumab, cancer
Two Obagi shareholders selling off their stakes
Yahoo/AP
Saturday, November 20, 2010 - 12:09pm
tags:
Obagi Medical Products
Exelixis: Up 32% With Room to Run
Motley Fool
Saturday, November 20, 2010 - 12:08pm
tags:
XL184, ovarian cancer, prostate cancer, Exelixis, Bristol-Myers Squibb
FDA orders painkiller Darvon off U.S. market
Marketwatch
Friday, November 19, 2010 - 1:43pm
tags:
Darvon, Darvocet, FDA, painkillers, Xanodyne
MELA Sciences Soars On FDA Approval
Forbes
Friday, November 19, 2010 - 1:41pm
tags:
MELA Sciences, FDA, melanoma, MelaFind
Kendle International: Outlook Improving, Valuation Compelling
Seeking Alpha
Friday, November 19, 2010 - 1:39pm
tags:
Kendle

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.